• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺高分化癌放射性碘治疗及经皮照射的病例选择与时机相关问题

Aspects of timing and selection of cases in radioiodine therapy and percutaneous irradiation of well differentiated carcinoma of the thyroid.

作者信息

Wiebe V, Schneider C, Franke H D

出版信息

Strahlentherapie. 1975 Jan;149(1):55-9.

PMID:1124555
Abstract

142 patients with well differentiated carcinoma of the thyroid were treated postoperatively by radioiodine and percutaneous irradiation according to a fixed schedule. Institution of radioiodine treatment and percutaneous irradiation within 6 months after surgery resulted in a low incidence of local tumor recurrences or of newly formed metastases, and in a high survival rate. Criteria are given, by which postoperative percutaneous irradiation may be omitted without risking impairment of therapeutical results.

摘要

142例高分化甲状腺癌患者术后按照固定方案接受放射性碘治疗和经皮照射。术后6个月内开始放射性碘治疗和经皮照射可使局部肿瘤复发或新形成转移灶的发生率降低,并提高生存率。文中给出了一些标准,依据这些标准,术后可省略经皮照射而不会有影响治疗效果的风险。

相似文献

1
Aspects of timing and selection of cases in radioiodine therapy and percutaneous irradiation of well differentiated carcinoma of the thyroid.甲状腺高分化癌放射性碘治疗及经皮照射的病例选择与时机相关问题
Strahlentherapie. 1975 Jan;149(1):55-9.
2
Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.青少年分化型甲状腺癌及其放射性碘在治疗中的作用:一项定性综述。
Endocr Relat Cancer. 2005 Dec;12(4):773-803. doi: 10.1677/erc.1.00880.
3
Radioiodine therapy in differentiated thyroid carcinoma.分化型甲状腺癌的放射性碘治疗
Rays. 2000 Apr-Jun;25(2):221-38.
4
Hürthle cell carcinoma: a clinicopathological study of thirteen cases.许特莱细胞癌:13例临床病理研究
Nucl Med Commun. 2006 Apr;27(4):377-9. doi: 10.1097/01.mnm.0000202862.74917.0c.
5
[Interstitial radiotherapy with 125I seeds in non-operable and non-radioiodine retaining local recurrences of differentiated and undifferentiated thyroid cancers].[125I 粒子间质放疗用于无法手术且不摄取放射性碘的分化型及未分化型甲状腺癌局部复发]
Wien Klin Wochenschr. 1990 Apr 27;102(9):277-80.
6
[The survival rate of patients with a differentiated thyroid carcinoma without primary percutaneous irradiation of the neck area].[无颈部区域初次经皮照射的分化型甲状腺癌患者的生存率]
Strahlenther Onkol. 1996 Jun;172(6):306-11.
7
Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study.甲状腺过氧化物酶:分化型甲状腺癌治疗后随访的肿瘤标志物?一项时间进程研究的结果
Cancer Detect Prev. 2000;24(6):524-30.
8
[Effect of the plan of therapy on prognosis in thyroid cancer].
Nuklearmedizin. 1983 Apr;22(2):97-105.
9
[Long-term course in differentiated thyroid gland carcinoma].[分化型甲状腺癌的长期病程]
Schweiz Med Wochenschr. 1992 Nov 28;122(48):1843-57.
10
Improving postoperative recurrence rates for carcinoma of the thyroid gland.提高甲状腺癌术后复发率。
Surg Gynecol Obstet. 1989 Nov;169(5):429-34.